The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 06, 2016

Filed:

Apr. 02, 2015
Applicants:

Dadong Zhang, Shanghai, CN;

Xu Cai, Shanghai, CN;

Chengyun Yue, Shanghai, CN;

Junfei LI, Sanghai, CN;

Yan HU, Shanghai, CN;

Peng Huang, Shanghai, CN;

Zhirong Tang, Shanghai, CN;

Qiyi Luo, Shanghai, CN;

Inventors:

Dadong Zhang, Shanghai, CN;

Xu Cai, Shanghai, CN;

Chengyun Yue, Shanghai, CN;

Junfei Li, Sanghai, CN;

Yan Hu, Shanghai, CN;

Peng Huang, Shanghai, CN;

Zhirong Tang, Shanghai, CN;

Qiyi Luo, Shanghai, CN;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61L 31/10 (2006.01); A61L 31/14 (2006.01); A61L 31/16 (2006.01); A61F 2/82 (2013.01);
U.S. Cl.
CPC ...
A61L 31/10 (2013.01); A61F 2/82 (2013.01); A61L 31/146 (2013.01); A61L 31/16 (2013.01); A61F 2250/0067 (2013.01); A61F 2250/0068 (2013.01); A61L 2300/416 (2013.01); A61L 2420/02 (2013.01);
Abstract

An interventional medical device and manufacturing method thereof. The interventional medical device comprises: a stent body (); a surface of the stent body () being provided with a drug releasing structure (), and drug in the drug releasing structure () being drug for suppressing proliferation of adventitial fibroblasts and a drug for suppressing proliferation of intimal and/or smooth muscle cells. In use, after interventional medical device is implanted into a human body, the drug for suppressing proliferation of adventitial fibroblasts carried thereon can promote the compensatory expansion of the vessel, and the drug for suppressing proliferation of intimal cells and/or smooth muscle cells carried thereon can suppress intimal proliferation of the vessel. The combination of the two kinds of drugs greatly reduces the occurrence rate of in-stent restenosis.


Find Patent Forward Citations

Loading…